Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Azora Therapeutics, Inc. (DE) (AZR)Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsMike Moyer is recorded as Head of Investor Relations at Azora Therapeutics, Inc. (DE) (AZR). Mike Moyer has spoken on 1 investor event across 1 company, most recently for Azora Therapeutics, Inc. (DE) on June 11, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO and Chairman), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.
“This morning, Adial Pharmaceuticals issued a press release announcing its acquisition of Azora Therapeutics, a concurrent private placement financing of up to $64 million, and updates to the leadership team.”
Biotechnology · Healthcare
Head of Investor Relations